Clinical Trials Browser

Chronic Disease, Fibrosis, Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasms

NCT05874492 2026-04-13

FIBROTHERME

Phase NA Recruiting

110 enrolled

BreastHead & Neck

Breast Neoplasms, Fibrosis, Head and Neck Neoplasms

NCT06096779 2026-04-03

Kirros

Phase 2 Recruiting

30 enrolled

Gastrointestinal

Digestive System Neoplasms, Fatty Liver, Fibrosis, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms

NCT07469319 2026-03-13

BISHOP

Phase NA Recruiting

617 enrolled

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

NCT05095714 2026-03-12

FASTRAK

Phase NA Recruiting

944 enrolled

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Liver Neoplasms

NCT07010315 2026-03-04

Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention

Recruiting

40 enrolled

Gastrointestinal

Fibrosis, Liver Diseases, Liver Neoplasms

NCT04485286 2026-02-27

Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury

Phase 2 Recruiting

72 enrolled

GastrointestinalThoracic

Radiation Fibrosis Syndrome, Fibrosis, Lung Neoplasms, Pancreatic Neoplasms

NCT04690972 2026-02-12

LivMOD

Recruiting

800 enrolled

Gastrointestinal

Hepatitis D, Fibrosis, Hepatitis B, Hepatitis C, Liver Diseases, Liver Neoplasms, Non-alcoholic Fatty Liver Disease

NCT06912763 2026-01-26

Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)

Phase 2 Recruiting

250 enrolled

Head & Neck

Fibrosis, Head and Neck Neoplasms, Lymphedema

Clinical Trials

PREMIUM

FIBROTHERME

Kirros

BISHOP

FASTRAK

Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention

Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury

LivMOD

Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)